Caption Management’s Wave Life Sciences WVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$131K Sell
22,500
-485,300
-96% -$3.22M ﹤0.01% 1507
2026
Q1
$3.68M Buy
507,800
+223,400
+79% +$2.91M 0.02% 621
2025
Q4
$4.83M Buy
284,400
+100,000
+54% +$1.02M 0.03% 533
2025
Q3
$1.35M Buy
184,400
+150,200
+439% +$1.22M 0.01% 1001
2025
Q2
$222K Hold
34,200
﹤0.01% 1247
2025
Q1
$276K Buy
+34,200
New +$374K ﹤0.01% 1211
2021
Q2
Sell
-551,800
Closed -$3.1M 1610
2021
Q1
$3.1M Buy
551,800
+501,800
+1,004% +$4.82M 0.07% 379
2020
Q4
$393K Sell
50,000
-42,000
-46% -$353K 0.01% 774
2020
Q3
$781K Buy
+92,000
New +$1.01M 0.02% 688
2020
Q1
Sell
-50,000
Closed -$400K 1111
2019
Q4
$400K Buy
+50,000
New +$1.23M 0.01% 661

Other funds holding WVE

Caption Management's WVE Position: Q2 2026 in Review

Caption Management reduced its Wave Life Sciences (WVE) stake by 79% in Q2 2026, selling an estimated $227K and leaving 9,000 shares worth $52.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1548.

Caption Management first reported a position in WVE in Q2 2019 and has held it in 9 quarters since. The position peaked at $2.1M in Q2 2019. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Caption Management held 9,000 shares of Wave Life Sciences worth $52.3K as of Q2 2026.
  • Caption Management sold 34,200 Wave Life Sciences shares in Q2 2026, an estimated $227K.
  • Wave Life Sciences made up ﹤0.01% of Caption Management's portfolio in Q2 2026, its #1548 holding.
  • Caption Management first reported a position in Wave Life Sciences in Q2 2019 and has held it in 9 quarters since.
  • Caption Management's Wave Life Sciences position peaked at $2.1M in Q2 2019.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.